Similar articles

• Neurochemical basis of dementia in Parkinson's disease.

  Hornykiewicz O, Kish SJ. Hornykiewicz O, et al. Can J Neurol Sci. 1984 Feb;11(1 Suppl):185-90. doi: 10.1017/s0317167100046382. Can J Neurol Sci. 1984. PMID: 6143610
• Late cognitive changes in Parkinson's disease with an emphasis on dementia.

  Mohr E, Mendis T, Grimes JD. Mohr E, et al. Adv Neurol. 1995;65:97-113. Adv Neurol. 1995. PMID: 7872155 Review. No abstract available.
• The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.

  Candy JM, Perry EK, Perry RH, Court JA, Oakley AE, Edwardson JA. Candy JM, et al. Prog Brain Res. 1986;70:105-32. doi: 10.1016/s0079-6123(08)64300-9. Prog Brain Res. 1986. PMID: 3554348 Review. No abstract available.
• The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.

  Liberini P. Liberini P. Funct Neurol. 1997 May-Aug;12(3-4):153-7. Funct Neurol. 1997. PMID: 9218969 Review. No abstract available.
• Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.

  Whitehouse PJ. Whitehouse PJ. Adv Neurol. 1987;45:393-7. Adv Neurol. 1987. PMID: 2881448 No abstract available.